Radioimmunotherapy of Malignancy Using Antibody Targeted Radionuclides

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1986.254
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Possibility of Cancer-Stem-Cell-Targeted Radioimmunotherapy for Acute Myelogenous Leukemia Using 211At-Cxcr4 Monoclonal Antibody

Scientific Reports
Multidisciplinary
2020English

Improving the Treatment of Non-Hodgkin Lymphoma With Antibody-Targeted Radionuclides

Cancer
Cancer ResearchOncology
2010English

An Appendix of Radionuclides Used in Targeted Alpha Therapy

Journal of Medical Imaging and Radiation Sciences
RadiologicalRadiologyNuclear MedicineUltrasound TechnologyImaging
2019English

Application of Radionuclides and Antibody-Drug Conjugates to Target Cancer

Cancer Studies and Molecular Medicine - Open Journal
2014English

Single-Antibody, Targeted Nanoparticle Delivery of Camptothecin

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2013English

Targeted Photodynamic Therapy of Breast Cancer Cells Using Antibody–phthalocyanine–gold Nanoparticle Conjugates

Photochemical and Photobiological Sciences
Theoretical ChemistryPhysical
2011English

213Bi Radioimmunotherapy With an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2013English

Antibody-Targeted Immunocarriers for Cancer Treatment

2016English

Therapeutic Efficacy Evaluation of Radioimmunotherapy With 90 Y-Labeled Anti-Podoplanin Antibody NZ-12 for Mesothelioma

Cancer Science
Cancer ResearchMedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy